| Code | 31824 | ||||||||||
| MA number | EU/1/95/003/012 | ||||||||||
| Product Form: | plv iol 2x14x300 µg (liek.inj.skl.+1,2 ml solv.-napl.skl.striek.+1 ihl.adap.+ 2 alk.tamp.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Bayer AG, Germany | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 20.07.2011 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC interferóny final 25 8 2014.pdf
|
| Safety feature | Yes |
| Data update: | 31.07.2018 |
